Proof-of-concept study of agomelatine (NRT 34) for the treatment of pain from fibromyalgia.

Trial Profile

Proof-of-concept study of agomelatine (NRT 34) for the treatment of pain from fibromyalgia.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Aug 2012

At a glance

  • Drugs Agomelatine (Primary)
  • Indications Fibromyalgia
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top